The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bioresorbable Ophthalmic Drug Delivery System Market Research Report 2025

Global Bioresorbable Ophthalmic Drug Delivery System Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1731556

No of Pages : 69

Ask Your Query

Synopsis
Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time.

Highlights
The global Bioresorbable Ophthalmic Drug Delivery System market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Bioresorbable Ophthalmic Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Bioresorbable Ophthalmic Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Bioresorbable Ophthalmic Drug Delivery System include Boehringer Ingelheim, Allergan, Re-Vana Therapeutics and PolyActiva, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Bioresorbable Ophthalmic Drug Delivery System in Hospitals is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Anterior Drug Delivery Methods, which accounted for % of the global market of Bioresorbable Ophthalmic Drug Delivery System in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioresorbable Ophthalmic Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioresorbable Ophthalmic Drug Delivery System.
The Bioresorbable Ophthalmic Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Bioresorbable Ophthalmic Drug Delivery System market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioresorbable Ophthalmic Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

  • Boehringer Ingelheim
  • Allergan
  • Re-Vana Therapeutics
  • PolyActiva

Product Type Insights
Global markets are presented by Bioresorbable Ophthalmic Drug Delivery System type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Bioresorbable Ophthalmic Drug Delivery System are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Bioresorbable Ophthalmic Drug Delivery System segment by Type

  • Anterior Drug Delivery Methods
  • Posterior Drug Delivery Methods

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Bioresorbable Ophthalmic Drug Delivery System market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Bioresorbable Ophthalmic Drug Delivery System market.
Bioresorbable Ophthalmic Drug Delivery System segment by Application

  • Hospitals
  • Clinics
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bioresorbable Ophthalmic Drug Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioresorbable Ophthalmic Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Bioresorbable Ophthalmic Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Bioresorbable Ophthalmic Drug Delivery System industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioresorbable Ophthalmic Drug Delivery System.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bioresorbable Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bioresorbable Ophthalmic Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

Index

1 Bioresorbable Ophthalmic Drug Delivery System Market Overview
1.1 Product Overview and Scope of Bioresorbable Ophthalmic Drug Delivery System
1.2 Bioresorbable Ophthalmic Drug Delivery System Segment by Type
1.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Anterior Drug Delivery Methods
1.2.3 Posterior Drug Delivery Methods
1.3 Bioresorbable Ophthalmic Drug Delivery System Segment by Application
1.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bioresorbable Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue 2017-2028
1.4.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales 2017-2028
1.4.3 Bioresorbable Ophthalmic Drug Delivery System Market Size by Region: 2017 Versus 2021 Versus 2028
2 Bioresorbable Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Bioresorbable Ophthalmic Drug Delivery System Manufacturing Sites, Area Served, Product Type
2.5 Bioresorbable Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.5.1 Bioresorbable Ophthalmic Drug Delivery System Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bioresorbable Ophthalmic Drug Delivery System Players Market Share by Revenue
2.5.3 Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bioresorbable Ophthalmic Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Bioresorbable Ophthalmic Drug Delivery System Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Bioresorbable Ophthalmic Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.3.1 North America Bioresorbable Ophthalmic Drug Delivery System Sales by Country
3.3.2 North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country
3.4.2 Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.5.1 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Region
3.5.2 Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.6.1 Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Country
3.6.2 Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country
3.7.2 Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bioresorbable Ophthalmic Drug Delivery System Historic Market Analysis by Type
4.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2022)
4.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2022)
4.3 Global Bioresorbable Ophthalmic Drug Delivery System Price by Type (2017-2022)
5 Global Bioresorbable Ophthalmic Drug Delivery System Historic Market Analysis by Application
5.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2022)
5.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2022)
5.3 Global Bioresorbable Ophthalmic Drug Delivery System Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Allergan Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Re-Vana Therapeutics
6.3.1 Re-Vana Therapeutics Corporation Information
6.3.2 Re-Vana Therapeutics Description and Business Overview
6.3.3 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Re-Vana Therapeutics Recent Developments/Updates
6.4 PolyActiva
6.4.1 PolyActiva Corporation Information
6.4.2 PolyActiva Description and Business Overview
6.4.3 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product Portfolio
6.4.5 PolyActiva Recent Developments/Updates
7 Bioresorbable Ophthalmic Drug Delivery System Manufacturing Cost Analysis
7.1 Bioresorbable Ophthalmic Drug Delivery System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bioresorbable Ophthalmic Drug Delivery System
7.4 Bioresorbable Ophthalmic Drug Delivery System Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bioresorbable Ophthalmic Drug Delivery System Distributors List
8.3 Bioresorbable Ophthalmic Drug Delivery System Customers
9 Bioresorbable Ophthalmic Drug Delivery System Market Dynamics
9.1 Bioresorbable Ophthalmic Drug Delivery System Industry Trends
9.2 Bioresorbable Ophthalmic Drug Delivery System Market Drivers
9.3 Bioresorbable Ophthalmic Drug Delivery System Market Challenges
9.4 Bioresorbable Ophthalmic Drug Delivery System Market Restraints
10 Global Market Forecast
10.1 Bioresorbable Ophthalmic Drug Delivery System Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bioresorbable Ophthalmic Drug Delivery System by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Bioresorbable Ophthalmic Drug Delivery System by Type (2023-2028)
10.2 Bioresorbable Ophthalmic Drug Delivery System Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bioresorbable Ophthalmic Drug Delivery System by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Bioresorbable Ophthalmic Drug Delivery System by Application (2023-2028)
10.3 Bioresorbable Ophthalmic Drug Delivery System Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bioresorbable Ophthalmic Drug Delivery System by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Bioresorbable Ophthalmic Drug Delivery System by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Bioresorbable Ophthalmic Drug Delivery System Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Bioresorbable Ophthalmic Drug Delivery System Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Bioresorbable Ophthalmic Drug Delivery System Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Bioresorbable Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers in 2021
Table 5. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Bioresorbable Ophthalmic Drug Delivery System Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Bioresorbable Ophthalmic Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Bioresorbable Ophthalmic Drug Delivery System Manufacturing Sites and Area Served
Table 11. Manufacturers Bioresorbable Ophthalmic Drug Delivery System Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bioresorbable Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioresorbable Ophthalmic Drug Delivery System as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 16. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Table 17. Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 19. North America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 20. North America Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 21. North America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 23. Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 24. Europe Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 25. Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 31. Latin America Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 33. Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 39. Global Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 40. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2022)
Table 41. Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Share by Type (2017-2022)
Table 43. Global Bioresorbable Ophthalmic Drug Delivery System Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Bioresorbable Ophthalmic Drug Delivery System Sales (K Units) by Application (2017-2022)
Table 45. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2022)
Table 46. Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Share by Application (2017-2022)
Table 48. Global Bioresorbable Ophthalmic Drug Delivery System Price by Application (2017-2022) & (US$/Unit)
Table 49. Boehringer Ingelheim Corporation Information
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product
Table 53. Boehringer Ingelheim Recent Developments/Updates
Table 54. Allergan Corporation Information
Table 55. Allergan Description and Business Overview
Table 56. Allergan Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Allergan Bioresorbable Ophthalmic Drug Delivery System Product
Table 58. Allergan Recent Developments/Updates
Table 59. Re-Vana Therapeutics Corporation Information
Table 60. Re-Vana Therapeutics Description and Business Overview
Table 61. Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product
Table 63. Re-Vana Therapeutics Recent Developments/Updates
Table 64. PolyActiva Corporation Information
Table 65. PolyActiva Description and Business Overview
Table 66. PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product
Table 68. PolyActiva Recent Developments/Updates
Table 69. Production Base and Market Concentration Rate of Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Bioresorbable Ophthalmic Drug Delivery System Distributors List
Table 72. Bioresorbable Ophthalmic Drug Delivery System Customers List
Table 73. Bioresorbable Ophthalmic Drug Delivery System Market Trends
Table 74. Bioresorbable Ophthalmic Drug Delivery System Market Drivers
Table 75. Bioresorbable Ophthalmic Drug Delivery System Market Challenges
Table 76. Bioresorbable Ophthalmic Drug Delivery System Market Restraints
Table 77. Global Bioresorbable Ophthalmic Drug Delivery System Sales Forecast by Type (2023-2028) & (K Units)
Table 78. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share Forecast by Type (2023-2028)
Table 79. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 80. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share Forecast by Type (2023-2028)
Table 81. Global Bioresorbable Ophthalmic Drug Delivery System Sales Forecast by Application (2023-2028) & (K Units)
Table 82. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share Forecast by Application (2023-2028)
Table 83. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 84. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share Forecast by Application (2023-2028)
Table 85. Global Bioresorbable Ophthalmic Drug Delivery System Sales Forecast by Region (2023-2028) & (K Units)
Table 86. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share Forecast by Region (2023-2028)
Table 87. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 88. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share Forecast by Region (2023-2028)
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bioresorbable Ophthalmic Drug Delivery System
Figure 2. Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Type in 2021 & 2028
Figure 3. Anterior Drug Delivery Methods Product Picture
Figure 4. Posterior Drug Delivery Methods Product Picture
Figure 5. Global Bioresorbable Ophthalmic Drug Delivery System Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Bioresorbable Ophthalmic Drug Delivery System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Bioresorbable Ophthalmic Drug Delivery System Market Size (2017-2028) & (US$ Million)
Figure 11. Global Bioresorbable Ophthalmic Drug Delivery System Sales (2017-2028) & (K Units)
Figure 12. Bioresorbable Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2021
Figure 13. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Bioresorbable Ophthalmic Drug Delivery System Players: Market Share by Revenue in 2021
Figure 15. Bioresorbable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Figure 17. Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Region in 2021
Figure 18. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Figure 19. Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Region in 2021
Figure 20. United States Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Bioresorbable Ophthalmic Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Bioresorbable Ophthalmic Drug Delivery System by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Bioresorbable Ophthalmic Drug Delivery System
Figure 45. Manufacturing Process Analysis of Bioresorbable Ophthalmic Drug Delivery System
Figure 46. Bioresorbable Ophthalmic Drug Delivery System Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock